FOM Technologies lands global MedTech customer as U.S. based Illumina Inc. places order

U.S. based Illumina Inc. awards FOM Technologies an order of our flagship slot-die coating equipment. The order is the first to a global corporation wanting to use the FOM Technologies R/D equipment within MedTech.

FOM Technologies is please to inform of the sale of our flagship coating system to Illumina Inc. in the USA. The sale was achieved in collaboration with our US distributor and the system is scheduled for delivery in 2022. The Illumina deal constitutes a brilliant example of our technology’s opportunities in the MedTech market space.

Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. Covid-19 test kits are a major revenue source.

Illumina head quarter is located in San Diego – California (US). The company is listed at NASDAQ stock exchange in the US under ticker code: ILMN

For more information on Illumina:
https://www.illumina.com/